StockData

Curis vs Eloxx Pharmaceuticals

CRIS and ELOX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CRIS and ELOX compare

Eloxx Pharmaceuticals is the larger company, worth 57 times as much as Curis ($51.5M against $911K).

Curis grew revenue faster over the last twelve months (−62.2% versus −100% for Eloxx Pharmaceuticals).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCRISELOX
Size and price
Market cap$911K$51.5M
Share price$0.436$12.75
Change, 1 year−98.1%1158990%
Change, 5 years−100.0%−97.9%
Beta (5Y)0.24–
Employees247
StockData Score
Total score77
Valuation score3 (better)1
Growth score00
Performance score01 (better)
Health score45 (better)
Dividend score00
Valuation
P/S0.2×–
P/B0.2× (better)1.1×
Fair value$6.86–
Margin of safety93.6%–
Growth
Revenue growth (TTM)−62.2% (better)−100%
Revenue growth, 5Y average−2.7%–
Profitability
Operating margin−203%–
Net margin−490%–
Return on equity–−54.3%
Financial health
Debt / equity0.000.00
Current ratio0.493.74 (better)
Altman Z-score−96.18−4.46 (better)
Piotroski F-score33
Dividends and buybacks
Buyback yield−2700%0.00% (better)
Shareholder yield−2700%0.00% (better)
Ownership
Held by institutions32.1%71.8%
Held by insiders20.4%42.6%
Insider net buying, 12 months$5.5K–
Short interest, % of float61.8%2.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.